Get the Stockscreener App
27.85
0.29%
0.08
Staar Surgical Co stock is traded at $27.85, with a volume of 476.25K.
It is up +0.29% in the last 24 hours and up +52.39% over the past month.
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.
See More
Previous Close:
$27.77
Open:
$27.9
24h Volume:
476.25K
Relative Volume:
0.31
Market Cap:
$1.38B
Revenue:
$224.45M
Net Income/Loss:
$-95.27M
P/E Ratio:
-14.43
EPS:
-1.93
Net Cash Flow:
$-43.74M
1W Performance:
-1.83%
1M Performance:
+52.39%
6M Performance:
+65.09%
1Y Performance:
-18.02%
1-Day Range:
$27.81
$28.34
1-Week Range:
$27.70
$28.63
52-Week Range:
$13.50
$38.60
Staar Surgical Co Stock (STAA) Company Profile
Name
Staar Surgical Co
Sector
Industry
Phone
(626) 303-7902
Address
1911 WALKER AVE, MONROVIA, CA
Compare STAA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
STAA
Staar Surgical Co
|
27.85 | 1.39B | 224.45M | -95.27M | -43.74M | -1.93 |
|
ISRG
Intuitive Surgical Inc
|
476.16 | 172.53B | 9.15B | 2.63B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
199.66 | 55.89B | 21.39B | 1.61B | 2.55B | 5.56 |
|
ALC
Alcon Inc
|
82.02 | 43.59B | 9.93B | 1.12B | 1.43B | 2.26 |
|
RMD
Resmed Inc
|
293.73 | 41.89B | 5.15B | 1.40B | 1.65B | 9.51 |
|
WST
West Pharmaceutical Services Inc
|
247.85 | 17.48B | 2.96B | 487.70M | 344.00M | 6.68 |
Staar Surgical Co Stock (STAA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-21-25 | Initiated | Wells Fargo | Equal Weight |
| Feb-12-25 | Downgrade | BTIG Research | Buy → Neutral |
| Feb-12-25 | Downgrade | Jefferies | Buy → Hold |
| Feb-12-25 | Downgrade | Mizuho | Outperform → Neutral |
| Feb-12-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jul-15-24 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Jun-11-24 | Upgrade | BTIG Research | Neutral → Buy |
| Mar-11-24 | Upgrade | Stifel | Hold → Buy |
| Dec-05-23 | Downgrade | Needham | Buy → Hold |
| Dec-04-23 | Initiated | Morgan Stanley | Equal-Weight |
| Sep-15-23 | Downgrade | The Benchmark Company | Buy → Hold |
| Aug-03-23 | Downgrade | Canaccord Genuity | Buy → Hold |
| Jun-07-23 | Downgrade | William Blair | Outperform → Mkt Perform |
| Apr-17-23 | Initiated | Piper Sandler | Neutral |
| Feb-06-23 | Downgrade | BTIG Research | Buy → Neutral |
| Dec-28-22 | Reiterated | BTIG Research | Buy |
| Dec-08-22 | Initiated | Stifel | Hold |
| Nov-07-22 | Upgrade | Sidoti | Neutral → Buy |
| Oct-14-22 | Resumed | Stephens | Overweight |
| Oct-13-22 | Initiated | Mizuho | Buy |
| Apr-08-22 | Initiated | Needham | Buy |
| Mar-28-22 | Upgrade | The Benchmark Company | Hold → Buy |
| Mar-18-22 | Upgrade | BTIG Research | Neutral → Buy |
| Jul-09-21 | Initiated | Oppenheimer | Perform |
| Jan-19-21 | Downgrade | The Benchmark Company | Buy → Hold |
| Oct-26-20 | Downgrade | Sidoti | Buy → Neutral |
| Aug-31-20 | Upgrade | Sidoti | Neutral → Buy |
| Aug-06-20 | Reiterated | The Benchmark Company | Buy |
| Jul-06-20 | Downgrade | Sidoti | Buy → Neutral |
| Jun-24-20 | Downgrade | BTIG Research | Buy → Neutral |
| Jun-15-20 | Initiated | Jefferies | Buy |
| Dec-04-19 | Initiated | BTIG Research | Buy |
| Sep-24-18 | Reiterated | The Benchmark Company | Buy |
| Aug-06-18 | Resumed | The Benchmark Company | Buy |
| Nov-20-17 | Reiterated | The Benchmark Company | Buy |
| Aug-14-17 | Reiterated | The Benchmark Company | Buy |
| Mar-03-17 | Reiterated | The Benchmark Company | Buy |
| May-18-16 | Upgrade | The Benchmark Company | Hold → Buy |
| Sep-10-13 | Resumed | The Benchmark Company | Buy |
| Feb-28-13 | Reiterated | The Benchmark Company | Buy |
| Nov-01-12 | Downgrade | Canaccord Genuity | Buy → Hold |
| Mar-02-12 | Initiated | Northland Securities | Outperform |
| Oct-25-11 | Reiterated | The Benchmark Company | Buy |
| Oct-12-10 | Initiated | Morgan Joseph | Buy |
| May-11-10 | Initiated | Benchmark | Buy |
View All
Staar Surgical Co Stock (STAA) Latest News
Alcon Cites Tariffs And Soft Market In Lowered Sales Outlook, Shares Fall - Benzinga
Alcon Q2 2025 slides: Announces $1.5B STAAR acquisition amid softening growth - Investing.com Australia
Alcon announces acquisition of STAAR Surgical - MarketScreener
$2.6B Quarter: Eye Care Giant Alcon Expands Empire with STAAR Acquisition and Breakthrough Dry Eye Drug - Stock Titan
Alcon Reports Second-Quarter 2025 Results, Launched Tryptyr and Announced Acquisition of STAAR Surgical - Ariva
Is STAAR Surgical Company likely to announce a buyback2025 Trading Volume Trends & Smart Allocation Stock Tips - thegnnews.com
Midday Stock Roundup: ICU Medical Soars, Willdan Group Down - Orange County Business Journal
A Quick Look at Today's Ratings for Staar Surgical(STAA.US), With a Forecast Between $28 to $28 - 富途牛牛
Penumbra, STAAR Surgical, CONMED, Acadia Healthcare, and Select Medical Shares Are Soaring, What You Need To Know - Yahoo Finance
Alcon announces purchase of STARR Surgical for $1.5 billion - MSN
Takeover Agreement with Alcon Sparks Sharp Weekly Gains for STAAR Surgical - Insider Monkey
11 Best Short-Term Stocks to Invest in - Insider Monkey
STAAR Surgical's largest holder demands books, records on Alcon deal (update) (STAA:NASDAQ) - Seeking Alpha
Shareholder Alert: The Ademi Firm Investigates Whether STAAR Surgical Company Is Obtaining a Fair Price for Its Public Shareholders - Bluefield Daily Telegraph
This Campbell's Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday - Benzinga
STAAR Surgical Q2 2025 net sales down 55% to USD 44.3M - Medical Buyer
Staar Surgical: Q2 Earnings Snapshot - New Haven Register
Alcon to acquire STAAR Surgical for $1.5B, sharpening focus on vision surgery - Tech Funding News
Stifel downgrades STAAR Surgical stock to Hold following Alcon acquisition By Investing.com - Investing.com Australia
Stifel downgrades STAAR Surgical stock to Hold following Alcon acquisition - Investing.com
Alcon to Buy Staar for $1.5 Billion in Vision Surgery Expansion - MSN
STAAR Surgical (NASDAQ:STAA) Delivers Strong Q2 Numbers - Yahoo Finance
STAAR Surgical earnings beat by $0.22, revenue topped estimates - Investing.com Australia
STAAR Surgical Earnings: China Sales Plunge 55%, But Global Markets Show 10% Growth in Latest Quarter - Stock Titan
Alcon agrees to acquire STAAR Surgical - Optometry Times
Switzerland: Alcon to acquire STAAR Surgical for US$1.5bn - Investors in Healthcare
Alcon to Acquire STAAR Surgical in $1.5 Billion Deal - The Globe and Mail
Alcon to acquire STAAR Surgical - Medical Buyer
The Ademi Firm Investigates Whether STAAR Surgical Company Is Obtaining a Fair Price for Its Public Shareholders - 富途牛牛
Healthcare Stocks Sent Mixed Signals As Deals And Politics Took Center Stage - Finimize
Alcons 260 Drop Amid 300M Volume Surge Ranks 409th as 15B STAAR Acquisition Drives Strategic Expansion - AInvest
Bright move: Alcon offers $1.5B for Staar Surgical - BioWorld MedTech
Why Are STAAR Surgical (STAA) Shares Soaring Today - uk.finance.yahoo.com
Johnson Fistel Investigates Fairness of Proposed Sale of STAAR Surgical - GlobeNewswire
Alcon Buys STAAR Surgical To Expand Eye Care Portfolio - Finimize
Gibson Dunn, Wachtell Advise On $1.5B Vision Implant Deal - Law360
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: STAAR Surgical Company (Nasdaq – STAA), Y-mAbs Therapeutics, Inc. (Nasdaq – YMAB), Couchbase, Inc. (Nasdaq – BASE), Core Scientific, Inc. (Nasdaq - GlobeNewswire Inc.
STAAR Surgical stock rating downgraded to Neutral by Sidoti on Alcon deal - Investing.com India
Stocks making the biggest moves midday: Pfizer, Palantir, Coinbase, Staar Surgical and more - CNBC
STAAR Surgical stock price target raised to $28 from $20 at Canaccord - Investing.com Nigeria
Alcon to Acquire Staar Surgical for $1.5B - Orange County Business Journal
Eyecare company with Berks locations announces acquisition - WFMZ.com
Top 2 Health Care Stocks You May Want To Dump In Q3 - 富途牛牛
Staar Surgical Co (STAA) Q2 2025 Earnings Report Preview: What To Expect - Yahoo Finance
STAAR Surgical stock soars after Alcon announces $1.5B acquisition By Investing.com - Investing.com South Africa
STAAR Surgical stock soars after Alcon announces $1.5B acquisition - Investing.com
Why Is STAAR Surgical Stock Skyrocketing Tuesday?Alcon (NYSE:ALC), Staar Surgical (NASDAQ:STAA) - Benzinga
Alcon to Buy STAAR Surgical for $1.5 Billion - Medical Product Outsourcing
STAAR Surgical: Takeover Offer Comes At A Significant Premium (NASDAQ:STAA) - Seeking Alpha
First Look: PG&E Surges, Intel Downgraded, and Alcon Acquires ST - GuruFocus
STAA to Be Acquired by Alcon for $28 Cash Per Share in Definitive Deal | STAA SEC FilingForm 8-K - Stock Titan
Staar Surgical Co Stock (STAA) Financials Data
Revenue
Net Income
Cash Flow
EPS
6.33%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):